[Japan IT Week] Pentas, introduces 'APACAR' application, a platform to share or trade anything among residents of the same apartment
[ No Woong Rae 2018-05-09 ]  
Email
Print

Pentas (CEO: Kim Seulmi) participated in 'Japan IT Week' held in Tokyo Big Sight from May 9th(Wed.) to 11th(Fri.) with support of Daejeon Information & Culture Industry Promotion Agency, and introduced the APACAR application, a platform to share or trade anything among residents of the same apartment.

APACAR, a sharing-in-apartment platform from Pentas, is an application that allows user to share or trade any items with a P2P car-sharing service as a start within the same apartment complex. The existing car-sharing service is B2C type like 'SOCAR' that companies provide cars and an individual uses it, but since APACAR supplies vehicles of residents not in use, it is possible more to realize sharing economy, and a user can pick up a car right in the same apartment complex, so users can quite conveniently use this service.   Any apartment residents can use APACAR page of their apartment. APACAR also provides a service that any items can be shared and traded among residents.

Kim Seulmi, the CEO of Pentas said "we are conducting surveys on visitors to figure out which point to focus on for overseas market entry where there are not apartments as many as there are in Korea, and through these surveys, we hope to have a chance to grow to the next level."

(Photo description: Kim Seulmi, the CEO of Pentas and a Japanese visitor answering to the surveys)

On the other hand, Daejeon Information & Culture Industry Promotion Agency is an industry promotion agency in Daejeon for Information Technology(IT), Software(SW), and Culture contents Technology and has a goal to realize a creative economy through convergence between ICT industries, and innovation which are based on ICT technology accumulated around Daedeok valley and the excellent ICT industrial environment in Daejeon. Daejeon Information & Culture Industry Promotion Agency supports excellent ICT companies for their successful overseas market entry with overseas exhibitions.

Global News Network 'AVING'
by No Woong Rae ( )

Copyright ⓒ 2020 AVING. All Rights Reserved.   메일보내기 인쇄하기
  AVING Around the World  
 http://www.naver.com 
 http://www.naver.com 
 http://newssearch.naver.com/search.naver?detail=0&display=20&ic=all&pd 
 http://newssearch.naver.com/search.naver?detail=0&display=20&ic=all&pd 
 http://www.naver.com 
 http://www.naver.com 
 http://www.naver.com 
 http://www.naver.com 
 http://www.naver.com 
 http://www.naver.com 
 http://172.31.0.59:3000/wisenutSearchAPI?type=news&display=100&sort=da 
 http://172.31.0.59:3000/wisenutSearchAPI?type=news&display=100&sort=da 
 http://www.naver.com 
 http://www.naver.com 
 http://www.naver.com 
 http://www.naver.com 
 http://go.mail.ru/search_images 
 http://www.baidu.com/s?wd=platesgme 
 http://www.baidu.com/s?wd=platesgme 
 http://m.search.naver.com/search.naver?where=m&query=be+among&sm=mtb_s 
 http://m.search.naver.com/search.naver?where=m&query=be+among&sm=mtb_s 
 http://www.baidu.com/s?wd=speciescne 
 http://www.baidu.com/s?wd=speciescne 
 http://go.mail.ru/search_images 
 http://go.mail.ru/search_images 
 http://go.mail.ru/search_images 
 http://go.mail.ru/search_images 
 http://go.mail.ru/search_images 
    latest Mobile/Computing
Major innovation companies of KHIDI Health Industry Startup I... 2020-05-07
A total of six companies participated in the MIK Hot Spot_KHIDI Health Industry Startup Innovation Center. △ PDxen △ G
[MIK HOT SPOT_KHIDI] Jeios's smart immunity analysis predicti... 2020-05-07
Although the mortality rate of COVID-19 is low compared to SARS and MERS, the spread rate is known to be as fast as the
[MIK HOT SPOT_KHIDI] Immunomax presents self-memory T cell-ba... 2020-05-07
Immunomax, which participated in MIK Hot Spot (Made in Korea Online Exhibition) KHIDI introduced its self-memory T cell-
[MIK HOT SPOT_KHIDI] Genome & Company on its establishment, s... 2020-05-07
Genome & Company was listed in KONEX in just three years and attracted Series C investment in just five years of bus
[MIK HOT SPOT_KHIDI] Damage in mitochondria causes disease! P... 2020-05-07
Paean Biotechnology is developing anti-inflammatory and anti-cancer drugs based on mitochondria separated from human umb
 
     
   
     

 
Copyright ⓒ 2020 AVING. All Rights Reserved.  Contact Webmaster for more Information